Vitamin A Deficiency Repletion
For adults with vitamin A deficiency, administer 10,000-25,000 IU oral vitamin A daily for 1-2 weeks, then recheck levels at 3 months; for severe deficiency with eye symptoms (xerophthalmia), use the emergency treatment protocol of 200,000 IU on day 1,200,000 IU on day 2, and 200,000 IU at 1-4 weeks later (half doses for infants <12 months). 1, 2
Treatment Algorithm Based on Clinical Presentation
For Mild-to-Moderate Deficiency (No Eye Symptoms)
- Adults: 10,000-25,000 IU oral vitamin A daily for 1-2 weeks 1
- Children 12 months-5 years: 200,000 IU every 3 months for prevention 2
- Infants <12 months: 100,000 IU every 3 months (or 200,000 IU every 6 months if 3-month dosing impractical) 2
- Recheck serum vitamin A levels at 3 months 1
For Severe Deficiency with Eye Signs (Medical Emergency)
Any patient presenting with xerophthalmia (night blindness, conjunctival xerosis, Bitot's spots, corneal xerosis, corneal ulceration, or keratomalacia) requires immediate high-dose treatment:
- Day 1: 200,000 IU oral vitamin A
- Day 2: 200,000 IU oral vitamin A
- Week 1-4: 200,000 IU oral vitamin A (third dose)
- Infants <12 months: Use half doses (100,000 IU per dose) 2
This emergency protocol applies to all patients with severe malnutrition (weight-for-height Z-score <-3) or any eye symptoms of vitamin A deficiency 2.
For Malabsorption or Treatment-Resistant Cases
If oral supplementation fails to improve serum levels or symptoms:
- Consider intramuscular vitamin A injections (100,000 IU for 3 days has been used successfully) 1, 3, 4
- Refer to specialist for assessment 1
- This is particularly important in short bowel syndrome, post-bariatric surgery, cystic fibrosis, or severe liver disease where fat malabsorption prevents adequate enteral uptake 3, 5
Special Populations
Pregnant/Lactating Women
- Postpartum mothers: 200,000 IU within 2 months of delivery to ensure adequate vitamin A in breast milk 2
- Third trimester: If postpartum dosing not feasible, give 100,000 IU during third trimester 2
- Caution: Keep vitamin A intake below 10,000 IU/day during first trimester due to teratogenic risk 6
Cystic Fibrosis Patients
The 2016 ESPEN guidelines provide specific guidance for this malabsorptive condition:
- Retinol (preformed): Start low, adapt rapidly to target normal serum reference range 6
- Beta carotene alternative: 1 mg/kg/day (maximum 50 mg/day) for 12 weeks, then maintenance dose (maximum 10 mg/day) 6
- Beta carotene is safer as it's subject to negative feedback control, unlike preformed retinol 6
Post-Bariatric Surgery
This population has high risk of deficiency (23% in one series) and requires:
- The standard adult repletion dose of 10,000-25,000 IU daily for 1-2 weeks 1
- Adolescents should be referred for specialist support 1
Critical Monitoring Points
- Recheck serum vitamin A at 3 months after initiating treatment 1, 6
- Annual monitoring once normal levels achieved 6
- Do not measure during acute infection—serum retinol falls with inflammation and doesn't reflect true tissue stores 6
- Consider adjusting for inflammatory markers (CRP, AGP) when interpreting levels 7
Common Pitfalls to Avoid
Toxicity risk: Chronic intake above 25,000 IU daily for >6 months or >100,000 IU for >6 months can cause toxicity (hepatotoxicity, increased intracranial pressure, bone/joint pain) 7. The upper limit is 10,000 IU/day for women of childbearing age 7. Water-miscible forms carry higher toxicity risk than oil-based supplements 6.
Delayed treatment of corneal disease: Corneal xerophthalmia is a medical emergency—any delay can result in irreversible blindness from keratomalacia 2, 8, 5. Start emergency high-dose protocol immediately on clinical suspicion, even before lab confirmation.
Inadequate dosing in malabsorption: The standard oral doses may be insufficient in conditions like short bowel syndrome, post-bariatric surgery, or severe pancreatic insufficiency. If no improvement after 3 months, switch to intramuscular route 1, 3.
Missing the diagnosis: In high-resource settings, vitamin A deficiency is underrecognized despite being common (27.7% in one recent U.S. tertiary center study) among patients with hepatic disease, malabsorption, or post-bariatric surgery 9. Maintain high index of suspicion in at-risk populations.
Evidence Strength Considerations
The most recent guideline evidence comes from the 2020 British Obesity and Metabolic Surgery Society guidelines 1, which provides the clearest adult dosing (10,000-25,000 IU daily for 1-2 weeks). The 1992 CDC/MMWR refugee health guidelines 2 remain the definitive source for emergency treatment protocols with eye symptoms, as this high-dose regimen (200,000 IU × 3 doses) has been validated across multiple populations and is still referenced in contemporary literature 10, 8, 11. The 2016 ESPEN-ESPGHAN-ECFS cystic fibrosis guidelines 6 offer valuable insights on beta carotene as a safer alternative in malabsorptive conditions.